Medicines play a huge role in aged care, which is why using them safely is paramount.
The MEGA-MAC project is a national initiative led by Monash University and funded by the Commonwealth Department of Health and Aged Care through the Medical Research Future Fund (MRFF). Its aim is to improve medication safety in residential aged care by supporting the 2022 Guiding Principles for Medication Management in Residential Aged Care Facilities.
Brightwater was pleased to support the project by testing the MEGA-MAC indicators at The Cove and The Oaks. These indicators help aged care homes check how well they are meeting the guiding principles and strengthen the safe use of medicines.
We’re proud to contribute to research and innovation that helps improve medication safety and deliver better outcomes for residents.
About Brightwater Research & Innovation Centre
Brightwater is the only aged care and disability provider in WA with a dedicated Research Centre, a hub of discovery and innovation since 2011.
Recognised by the Australian Association of Gerontology (AAG) as a Collaborating Research Centre, we collaborate with leading universities, research institutes and providers across Australia to advance research, policy and practice in brain health, ageing well, brain injury rehabilitation, independence, dementia care, quality of life, Huntington’s Disease and nutrition.
By connecting the knowledge of clients, staff, families and researchers, the Brightwater Research & Innovation Centre drives evidence-based insights that translate into better care, stronger communities and healthier futures.
Learn more about the Brightwater Research & Innovation Centre.
